Evaluating the clinical utility of early exome sequencing in diverse pediatric outpatient populations in the North Carolina Clinical Genomic Evaluation of Next-generation Exome Sequencing (NCGENES) 2 study: a randomized controlled trial.

Saved in:
Bibliographic Details
Title: Evaluating the clinical utility of early exome sequencing in diverse pediatric outpatient populations in the North Carolina Clinical Genomic Evaluation of Next-generation Exome Sequencing (NCGENES) 2 study: a randomized controlled trial.
Authors: Staley BS; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Campus Box #7295, Chapel Hill, NC, 27599-7295, USA. bstaley@unc.edu., Milko LV; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Waltz M; Department of Social Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Griesemer I; Department of Heath Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.; Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Mollison L; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Grant TL; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Farnan L; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, 27599, USA., Roche M; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.; Department of Pediatrics, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, 27599, USA., Navas A; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Lightfoot A; Department of Heath Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.; Center for Health Promotion and Disease Prevention, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Foreman AKM; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., O'Daniel JM; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., O'Neill SC; Department of Oncology, Georgetown University, Washington, DC, 20007, USA., Lin FC; Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Roman TS; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Brandt A; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Powell BC; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Rini C; Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA., Berg JS; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA., Bensen JT; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Campus Box #7295, Chapel Hill, NC, 27599-7295, USA.
Source: Trials [Trials] 2021 Jun 14; Vol. 22 (1), pp. 395. Date of Electronic Publication: 2021 Jun 14.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1745-6215
DOI:10.1186/s13063-021-05341-2